Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Plos One|March 31, 2017
Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markersShinichiro Ryuge, Yuichi Sato, Ryo Nagashio, et al.
Clinical Lung Cancer|May 28, 2018
Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non-Small-Cell Lung Cancer: A Prospective Observational StudyTomoya Fukui, Yuriko Okuma, Yoshiro Nakahara, et al.
Thoracic Cancer|January 17, 2019
Questionnaire survey on patient awareness of invasive rebiopsy in advanced non-small cell lung cancerTomoya Fukui, Mikiko Ishihara, Masashi Kasajima, et al.
Lung Cancer (Amsterdam, Netherlands)|February 29, 2008
Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumorsMasahiro Endo, Kazuo Nakagawa, Yasuhisa Ohde, et al.
The American Journal of Pathology|May 13, 2018
Cytoskeleton-Associated Protein 4 Is a Novel Serodiagnostic Marker for Lung CancerKengo Yanagita, Ryo Nagashio, Shi-Xu Jiang, et al.
Cancer Management and Research|December 1, 2021
A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with EGFR Mutation-Positive Non-Small Cell Lung CancerSatoshi Igawa, Masashi Kasajima, Taihei Ono, et al.
Medical Oncology (Northwood, London, England)|September 26, 2009
Actual status of adjuvant chemotherapy for non-small-cell lung cancer at one Japanese cancer center: the need for increased cooperation between medical oncologists and surgeonsTakehito Shukuya, Toshiaki Takahashi, Akihiro Tamiya, et al.
International Journal of Clinical Oncology|March 4, 2010
Evaluation of S-1 as third- or further-line chemotherapy in advanced non-small-cell lung cancerAkira Ono, Tateaki Naito, Haruyasu Murakami, et al.
Investigational New Drugs|January 12, 2023
Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinomaHiroya Manaka, Satoshi Igawa, Michiko Yamamoto, et al.
Oncology Research and Treatment|September 27, 2017
Clinicopathological Significance of S100A14 Expression in Lung AdenocarcinomaKen Katono, Yuichi Sato, Makoto Kobayashi, et al.
Pageof 11